Funder: National Institutes of Health
Due Dates (Anticipated): September 2026 (Full application deadline, projected)
Funding Amounts: Estimated total funding: $6,000,000; ~4 awards expected; award size/duration not specified.
Summary: Supports translational development of next-generation diagnostic and therapeutic devices for neurological and addiction disorders, advancing technologies toward readiness for first-in-human trials.